Concerns and motivations about COVID-19 vaccination.
Concerns and motivations about COVID-19 vaccination.
复制标题
DOI：
10.1016/s1473-3099(20)30926-9
复制
发表时间：
2021-03
期刊：
影响因子：
--
通讯作者：
McCaffery KJ
中科院分区：
文献类型：
--
作者：
Dodd RH;Pickles K;Nickel B;Cvejic E;Ayre J;Batcup C;Bonner C;Copp T;Cornell S;Dakin T;Isautier J;McCaffery KJ
全球有超过200种COVID-19疫苗正在开发中，各国政府已达成协议，以获得提前剂量。但准入只是一个问题。在疫情期间，各国接受COVID-19疫苗的意愿差异很大。在《柳叶刀传染病》中，我们展示了2020年4月在澳大利亚收集的数据1，该数据表明，如果疫苗可用，86%的受访者（4362人中的3741人）愿意接种COVID-19疫苗。此外，COCONEL集团2在2020年3月表示，74%的法国公民将接种疫苗。在2020年4月至7月期间，接种疫苗的意愿从美国的58% 3到英国的64% 4和新西兰的74%不等。新西兰的数据显示，接种疫苗的最常见原因是保护
More than 200 COVID-19 vaccines are in development worldwide, with governments securing deals to access advance doses. But access is only one issue. Willingness to accept a COVID-19 vaccine when it becomes available has varied considerably across countries over the course of the pandemic. In The Lancet Infectious Diseases, we presented data collected in Australia in April, 2020, 1 which suggested 86% of people surveyed (3741 of4362) would be willing to vaccinate against COVID-19 if a vaccine became available. Furthermore, the COCONEL group2 showed in March, 2020, that 74% of French citizens would vaccinate. Between April and July, 2020, willingness to vaccinate has ranged from 58% in the USA3 to 64% in the UK4 and 74% in New Zealand. 5 The New Zealand data showed that the most commonly reported reasons to get vaccinated were to protect